1400 Results for "

Reversible

" in MedChemExpress (MCE) Product Catalog:
Products (1400)

1400 Results for "Reversible" in MCE Product Catalog:

24
24 Cited Publications
Cat. No.: HY-10453
CAS No.: 1072833-77-2
Purity:  99.30%
Synonyms: MLN2238
Target:  

Proteasome Autophagy

Research Areas:  

Cancer

Ixazomib (MLN2238) is a selective, potent, and reversible proteasome inhibitor, which inhibits the chymotrypsin-like proteolytic (β5) site of the 20S proteasome with an IC50 of 3.4 nM (Ki of 0.93 nM).
loading...
    loading...
24
24 Cited Publications
Cat. No.: HY-B0034
CAS No.: 120011-70-3
Synonyms: E2020
Target:  

Cholinesterase (ChE)

Research Areas:  

Neurological Disease Cancer

Donepezil Hydrochloride (E2020) is a reversible, selective AChE inhibitor with an IC50 of 6.7 nM for AChE activity. Donepezil shows high selectivity for AChE over BuChE . Donepezil exhibits neuroprotective effect on Aβ42 neurotoxicity .
loading...
    loading...
24
24 Cited Publications
Cat. No.: HY-125286
CAS No.: 2105904-82-1
Purity:  99.71%
Target:  

CD73

Research Areas:  

Cancer

AB-680 is a highly potent, reversible and selective inhibitor of CD73 (an ecto-nucleotidase), with a Ki of 4.9 pM for hCD73, displays >10,000-fold selectivity over related ecto-nucleotidases CD39. Anti-tumor activity .
loading...
    loading...
23
23 Cited Publications
Cat. No.: HY-B0879A
CAS No.: 129-46-4
Synonyms: Suramin hexasodium salt
Suramin sodium salt (Suramin hexasodium salt) is a reversible and competitive protein-tyrosine phosphatases (PTPases) inhibitor . Suramin sodium salt is a potent inhibitor of sirtuins: SirT1 (IC50=297 nM), SirT2 (IC50=1.15 μM), and SirT5 (IC50=22 μM) . Suramin sodium salt is a competitive inhibitor of reverse transcriptase (DNA topoisomerase II: IC50=5 μM) . Suramin sodium salt is a potent SARS-CoV-2 RNA-dependent RNA polymerase (RdRp) inhibitor . Suramin sodium salt efficiently inhibits IP5K and is an antiparasitic, anti-neoplastic and anti-angiogenic agent .
loading...
    loading...
21
21 Cited Publications
Cat. No.: HY-50877
CAS No.: 929095-18-1
Synonyms: GSK461364A
Research Areas:  

Cancer

GSK461364 is a selective, reversible and ATP-competitive Polo-like kinase 1 (PLK1) inhibitor with a Ki value of 2.2 nM.
loading...
    loading...
21
21 Cited Publications
Cat. No.: HY-14248
CAS No.: 112809-51-5
Purity:  99.95%
Synonyms: CGS 20267
Letrozole (CGS 20267) is a potent, selective, reversible and orally active non-steroidal inhibitor of aromatase, with an IC50 of 11.5 nM. Letrozole selective inhibits estrogen biosynthesis, and can be used for the research of breast cancer .
loading...
    loading...
21
21 Cited Publications
Cat. No.: HY-18637
CAS No.: 668467-91-2
Research Areas:  

Neurological Disease

LDN-57444 is a reversible, competitive and site-directed inhibitor of ubiquitin C-terminal hydrolase L1 (UCH-L1), with an IC50 of 0.88 μM and a Ki of 0.40 μM; LDN-57444 also suppresses UCH-L3 activity, with an IC50 of 25 μM.
loading...
    loading...
21
21 Cited Publications
Cat. No.: HY-128717
CAS No.: 1629013-22-4
Purity:  99.19%
Synonyms: EPZ019997
Research Areas:  

Cancer

GSK3368715 (EPZ019997) is an orally active, reversible, and S-adenosyl-L-methionine (SAM) uncompetitive type I protein arginine methyltransferases (PRMTs) inhibitor (IC50=3.1 nM (PRMT1), 48 nM (PRMT3), 1148 nM (PRMT4), 5.7 nM (PRMT6), 1.7 nM (PRMT8)). GSK3368715 (EPZ019997) produces a shift in arginine methylation states, alters exon usage, and has strong anti-cancer activity .
loading...
    loading...
21
21 Cited Publications
Cat. No.: HY-128717A
CAS No.: 1628925-77-8
Purity:  99.96%
Synonyms: EPZ019997 dihydrochloride
Research Areas:  

Cancer

GSK3368715 dihydrochloride (EPZ019997 dihydrochloride) is an orally active, reversible, and S-adenosyl-L-methionine (SAM) uncompetitive type I protein arginine methyltransferases (PRMTs) inhibitor (IC50=3.1 nM (PRMT1), 48 nM (PRMT3), 1148 nM (PRMT4), 5.7 nM (PRMT6), 1.7 nM (PRMT8)). GSK3368715 dihydrochloride (EPZ019997 dihydrochloride) produces a shift in arginine methylation states, alters exon usage, and has strong anti-cancer activity .
loading...
    loading...
19
19 Cited Publications
Cat. No.: HY-109124
CAS No.: 1613267-49-4
Purity:  98.45%
Synonyms: VNRX-5133
Research Areas:  

Infection

Taniborbactam (VNRX-5133) is a reversible and selective boronic acid-containing pan-spectrum β-lactamase inhibitor with IC50s of 8-530 nM. Taniborbactam has IC50s of 30 nM, 32 nM, 42 nM, 20 nM for KPC-2, AmpC, OXA-48, and VIM-2. Taniborbactam is against Gram-negative bacteria .
loading...
    loading...
19
19 Cited Publications
Cat. No.: HY-109124A
CAS No.: 2244235-49-0
Purity:  99.97%
Synonyms: VNRX-5133 hydrochloride
Research Areas:  

Infection

Taniborbactam hydrochloride (VNRX-5133 hydrochloride) is a reversible and selective boronic acid-containing pan-spectrum β-lactamase inhibitor with IC50s of 8-530 nM. Taniborbactam hydrochloride has IC50s of 30 nM, 32 nM, 42 nM, 20 nM for KPC-2, AmpC, OXA-48, and VIM-2. Taniborbactam hydrochloride is against Gram-negative bacteria .
loading...
    loading...
19
19 Cited Publications
Cat. No.: HY-13917
CAS No.: 1061353-68-1
Purity:  99.88%
Synonyms: VS-4718; SR-2516
Target:  

FAK Apoptosis

Research Areas:  

Cancer

PND-1186 (VS-4718) is a potent, highly-specific and reversible inhibitor of FAK with an IC50 of 1.5 nM. PND-1186 selectively promotes tumor cell apoptosis .
loading...
    loading...
19
19 Cited Publications
Cat. No.: HY-13917A
CAS No.: 1356154-94-3
Purity:  99.92%
Synonyms: VS-4718 hydrochloride; SR-2516 hydrochloride
Target:  

FAK Apoptosis

Research Areas:  

Cancer

PND-1186 hydrochloride (VS-4718 hydrochloride) is a potent, highly-specific and reversible inhibitor of FAK with an IC50 of 1.5 nM. PND-1186 hydrochloride selectively promotes tumor cell apoptosis .
loading...
    loading...
19
19 Cited Publications
Cat. No.: HY-17543
CAS No.: 1572414-83-5
Target:  

Deubiquitinase

Research Areas:  

Cancer

ML-323 is a reversible, potent USP1-UAF1 inhibitor with IC50 of 76 nM in a Ub-Rho assay. The measured inhibition constants of ML-323 for the free enzyme (Ki) is 68 nM.
loading...
    loading...
18
18 Cited Publications
Cat. No.: HY-156498
CAS No.: 2765082-12-8
Purity:  99.48%
Research Areas:  

Cancer

RMC-7977 is an orally active triple-complex RAS inhibitor that can simultaneously bind to cyclophilin A (CYPA) (Kd = 195 nM) and KRAS (G12V) (Kd = 292 μM). It exhibits broad-spectrum inhibitory activity against KRAS, NRAS, and HRAS proteins and their various wild-type and mutant variants. RMC-7977 induces apoptosis by inhibiting the phosphorylation of ERK, CRAF, and RSK, as well as increasing PARP cleavage. This leads to tumor regression, reduces resistance in KRAS G12C cancer models, and demonstrates good tolerability across various RAS cancer models .
loading...
    loading...
17
17 Cited Publications
Cat. No.: HY-18690A
CAS No.: 1650550-25-6
Synonyms: AG-221 mesylate
Research Areas:  

Cancer

Enasidenib mesylate is a first-in-class, oral, potent, reversible, selective inhibitor of the IDH2 mutant enzymes.
loading...
    loading...
17
17 Cited Publications
Cat. No.: HY-18690
CAS No.: 1446502-11-9
Synonyms: AG-221
Research Areas:  

Cancer

Enasidenib is an oral, potent, reversible, selective inhibitor of the IDH2 mutant enzymes, with IC50s of 100 and 400 nM against IDH2 R140Q and IDH2 R172K, respectively.
loading...
    loading...
17
17 Cited Publications
Cat. No.: HY-N0063
CAS No.: 65995-63-3
Punicalagin is a polyphenol ingredient isolated from Pomegranate (Punica granatum L.) or the leaves of Terminalia catappa L.. Punicalagin is a reversible and non-competitive 3CL pro inhibitor and inhibits SARS-CoV-2 replication in vitro. Punicalagin is an anti-hepatitis B virus (HBV) agent and has antioxidant, anti-inflammatory, and anticancer effects. Punicalagin has the potential for the research of COVID-19 .
loading...
    loading...
17
17 Cited Publications
Cat. No.: HY-10580
CAS No.: 667463-62-9
Purity:  99.31%
Synonyms: 6-Bromoindirubin-3'-oxime; BIO; MLS 2052
Target:  

GSK-3 CDK Apoptosis

Research Areas:  

Cancer

GSK 3 Inhibitor IX (6-Bromoindirubin-3'-oxime; BIO) is a potent, selective, reversible and ATP-competitive inhibitor of GSK-3α/β and CDK1-cyclinB complex with IC50s of 5 nM/320 nM/80 nM for (GSK-3α/β)/CDK1/CDK5, respectively.
loading...
    loading...
16
16 Cited Publications
Cat. No.: HY-13050
CAS No.: 848942-61-0
Purity:  99.93%
Synonyms: AZD-8931
Target:  

EGFR

Research Areas:  

Cancer

Sapitinib (AZD-8931) is a reversible, ATP competitive EGFR inhibitor of with IC50s of 4, 3 and 4 nM for EGFR, ErbB2 and ErbB3 in cells, respectively.
loading...
    loading...